HC Wainwright & Co. Reiterates Buy on Opus Genetics, Maintains $8 Price Target

Benzinga · 1d ago
HC Wainwright & Co. analyst Matthew Caufield reiterates Opus Genetics (NASDAQ:IRD) with a Buy and maintains $8 price target.